Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers
CBTAC
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to determine whether a comprehensive cognitive-behavioral therapy-based, multi-component treatment programme is effective in the treatment of neuropsychiatric symptoms of patients with mild Alzheimer's dementia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2 alzheimer-disease
Started Feb 2011
Longer than P75 for phase_2 alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 3, 2011
CompletedFirst Posted
Study publicly available on registry
January 10, 2011
CompletedStudy Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedNovember 6, 2017
November 1, 2017
6.6 years
January 3, 2011
November 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in Geriatric Depression Scale (GDS)
Pre-treatment, posttreatment (expected average of 9 months after protreatment), 6- and 12-months follow-up
Secondary Outcomes (10)
Change from baseline in Neuropsychiatric Inventory (NPI)
Pre-treatment, post-treatment (expected average of 9 months after protreatment), 6- and 12-months follow-up
Change from baseline in Bayer-Activities of Daily Living (B-ADL)
Pre-treatment, post-treatment (expected average of 9 months after protreatment), 6- and 12-months follow-up
Change from baseline in Stress Coping Inventory (SCI)
Pre-treatment, post-treatment (expected average of 9 months after protreatment), 6- and 12-months follow-up
Change from baseline in Apathy Evaluation Scale (AES)
Pre-treatment, post-treatment (expected average of 9 months after protreatment), 6- and 12-months follow-up
Caregiver: Change from baseline in Center for Epidemiologic Studies Depression Scale (CES-D)
Pre-treatment, post-treatment (expected average of 9 months after protreatment), 6- and 12-months follow-up
- +5 more secondary outcomes
Study Arms (2)
Cognitive Behavioral Therapy (CBT)
EXPERIMENTALComprehensive, CBT-based, multi-component treatment. Comprehensive CBT intervention in addition to standard treatment
Treatment as usual (TAU)
ACTIVE COMPARATORStandard Treatment (medical and psychosocial)
Interventions
It includes eight modules: diagnosis and goal setting; psychoeducation; engagement in pleasant activities; cognitive restructuring; live review; training caregiver in behavior man-agement techniques; interventions for the caregiver; and couples counselling. It consists of 20 weekly sessions (plus appr. 5 single session with caregiver).
Each patient/caregiver must receive at least three out of six interventions: (1) psychoeducation on dementia and treatment of dementia (oral and written); (2) appropriate medical treatment; (3) social counseling by specialized staff; (4) memory training in group setting; (5) self-help group for the patient; (6) self-help group for the caregiver.
Eligibility Criteria
You may qualify if:
- Patients have to meet NINCDS-ADRDA criteria for probable or possible AD (McKhann et al., 1984). Mixed Alzheimer and Vascular dementia cases will also be included.
- Only AD cases with a mild dementia severity will be included, determined by the Clinical Dementia Rating (CDR) scale (i.e. scores of 0.5 or 1, Morris, 1993) and by the Mini Mental State Examination (MMSE) (i.e. scores of 20 or more, Folstein, Folstein, \& McHugh, 1975).
- The patient must suffer under any non-cognitive symptom that motivates him to accept psy-chotherapeutic help.
- A caregiver must be available to take part in most of the therapy sessions.
You may not qualify if:
- concomitant alcohol or drug addiction and a history of a malignant disease, severe organ failure, metabolic or hematologic disorders, neurosurgery or neurological condition such as Parkinson's disease, epilepsy, postencephalitic and postconcussional syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Zurichlead
- Psychiatric University Hospital, Zurichcollaborator
Study Sites (1)
Psychiatric University Hospital, Clinic for Geriatric Medicine
Zurich, 8032, Switzerland
Related Publications (4)
Forstmeier S, Maercker A. Problems of aging. Psychotherapy in older age [German]. Göttingen, Germany: Hogrefe. 2008.
BACKGROUNDForstmeier S, Maercker A. Psychotherapie im Alter. Psychotherapeutenjournal 4: 340-352, 2007
BACKGROUNDForstmeier S, Maercker A, Savaskan E, Roth T. Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial. Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.
PMID: 26576633BACKGROUNDForstmeier S, Maercker A, Bohli L, Savaskan E, Roth T. Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): results of a randomised controlled trial. Aging Ment Health. 2025 Feb;29(2):359-368. doi: 10.1080/13607863.2024.2393748. Epub 2024 Aug 20.
PMID: 39164933DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon Forstmeier, Ph.D.
University of Zurich
- STUDY CHAIR
Andreas Maercker, M.D.,Ph.D.
University of Zurich
- STUDY CHAIR
Egemen Savaskan, M.D.
Psychiatric University Hospital, Zurich
- STUDY CHAIR
Tanja Roth, Ph.D.
Psychiatric University Hospital, Zurich
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D.
Study Record Dates
First Submitted
January 3, 2011
First Posted
January 10, 2011
Study Start
February 1, 2011
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
November 6, 2017
Record last verified: 2017-11